Editor’s Choice: Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma

Editorial: Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma

Hosted by:
Warner Huh, MD, Deputy Editor of Gynecologic Oncology

Featuring:
Tullia Rushton, MD

Editor’s Choice: The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study

Editorial: Hormonal maintenance therapy for advance low grade serous ovarian carcinoma appears to be of benefit – That's a relief!

Editor’s Choice: Implementation of a financial navigation program in gynecologic oncology

Editorial: Financial toxicity: moving from describing the problem toward developing interventions

Hosted by:
Diane Yamada, MD

Featuring:
Katharine M. Esselen, MD
Margaret Liang, MD

Editor’s choice: The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma

Editorial: Is substantial lymphovascular space invasion in FIGO stage I endometrial carcinoma ready for primetime in deciding adjuvant treatment?

Hosted by:
Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology

Featuring:
Mohamed Elshaikh, MD
Beriwal Sushil MD

Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva

Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer

Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology

Featuring:  Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada

Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada

Dr Scott Glaser, MD, City of Hope, USA

Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists

Editorial: Who you gonna call?

Hosted by:
David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology

Featuring:
M. Dwight Chen, MD, Palo Alto Foundation Medical Group/Sutter Health
Connor C. Wang, MD, Northwestern University Feinberg School of Medicine
Emma Barber, MD, MS, Northwestern University Feinberg School of Medicine

Reviews: 2023 changes to FIGO endometrial cancer staging: Counterpoint; 2023 FIGO staging system for endometrial cancer: The evolution of the revolution

Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study

Editor’s Choice Paper: 
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers

Editorial:
The importance of family-focused care in the setting of advanced gynecological cancers

Hosted by:
Sean Dowdy, MD, Associate Editor of Gynecologic Oncology



Featuring:
Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical School
Allison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center

Editor’s Choice Paper: 
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma

Editorial:
What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology



Featuring:
Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical College
Gretchen Glaser, MD, Mayo Clinic 
John Weroha, MD, Mayo Clinic